These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25691815)

  • 21. The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications.
    McMahon T; Tucci J
    Pharm Pract (Granada); 2011 Jul; 9(3):141-7. PubMed ID: 24367468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists.
    Meloche M; Kwon HJ; Letarte N; Bussières JF; Vadnais B; Hurlimann T; Lavoie A; Beauchesne MF; de Denus S
    Pharmacogenomics; 2020 Mar; 21(4):235-245. PubMed ID: 32077363
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
    Cadogan CA; Ryder SA
    Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.
    Albitar L; Alchamat GA
    BMC Health Serv Res; 2021 Oct; 21(1):1031. PubMed ID: 34592972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions.
    Pépin MA; Otis AS; Tremblay Z; Boulé M; Lebel D; Major P; Lortie A; Pinchefsky E; Rossignol E; Carleton B; Bussières JF; Métras MÉ
    Per Med; 2022 Sep; 19(5):423-434. PubMed ID: 35830229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel.
    Ho TT; Bell G; Gammal RS; Gregornik D; Wake DT; Dunnenberger HM
    Am J Health Syst Pharm; 2022 Sep; 79(19):1634-1644. PubMed ID: 35876085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics competencies in pharmacy practice: A blueprint for change.
    Roederer MW; Kuo GM; Kisor DF; Frye RF; Hoffman JM; Jenkins J; Weitzel KW
    J Am Pharm Assoc (2003); 2017; 57(1):120-125. PubMed ID: 27816542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics: Precision Pharmacy in 503A Compounding.
    Drummond J; Bennet D; Allen LV
    Int J Pharm Compd; 2018; 22(2):95-107. PubMed ID: 29877857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics: has the time come for pharmacists to embrace and implement the science?
    Beier MT; Panchapagesan M; Carman LE
    Consult Pharm; 2013 Nov; 28(11):696-711. PubMed ID: 24217190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge.
    Alsaloumi L; Abdi A; Tosun Ö; Başgut B
    Int J Clin Pharm; 2019 Oct; 41(5):1299-1306. PubMed ID: 31267362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital pharmacists' awareness of a new antibiotic guideline in the UK: implications for practice.
    Woodford EM; Wilson KA; Marriott JF
    Pharm World Sci; 2005 Jun; 27(3):215-9. PubMed ID: 16096890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations.
    Bank PC; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Feb; 18(3):215-225. PubMed ID: 28112992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of pharmacogenetic testing in compounding pharmacy.
    Fichter B; Heintzelman T; Hurst S; Fitzsimmons D; Mailloux C
    Int J Pharm Compd; 2013; 17(6):452-7. PubMed ID: 24579294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
    Madhaven S
    J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
    Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
    BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the Discrepancies between Pharmacist and Patient Perception of the Pharmacist's Role as an Advisor on Drug Therapy Based on Social Science Theory.
    Oshima S; Senoo K; Negishi A; Akimoto H; Ohara K; Inoue N; Ohshima S; Kutsuma N; Juni K; Kobayashi D
    Biol Pharm Bull; 2016; 39(3):313-22. PubMed ID: 26700216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.